CELL INTELLIGENCE · 肿瘤细胞治疗研究

去中心化 CAR-T 生产：临床、经济和监管视角。Worldwide Network for Blood & Marrow Transplantation (WBMT) 特别文章

Decentralized CAR-T production: clinical, economic, and regulatory perspectives. Worldwide Network for Blood & Marrow Transplantation (WBMT) special a

智能药物递送系统用于免疫治疗药物：聚焦于基于生物/生物源性平台的智能递送在癌症免疫治疗中的应用

Smart drug delivery systems for immunotherapeutic agents: focus on biological/biogenic platform-based intelligent delivery in cancer immunotherapy.

改善 CAR-T 细胞治疗对病毒性疾病、癌症和自身免疫性疾病疗效的分子机制最新进展

Recent advances in molecular mechanisms to improve the efficacy of CAR-T cell therapy for viral diseases, cancer, and autoimmune diseases.

CRISPR 工程化 CAR-T 细胞治疗 EB 病毒相关鼻咽癌：新兴治疗前景综述

CRISPR-Engineered CAR-T Cell Therapy for Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma: A Review of Emerging Therapeutic Prospects.

化身原则：外泌体动力学指导肿瘤适应与下一代治疗策略

The avatar principle: exosomal dynamics guiding tumor adaptation and next-generation therapeutic strategies.

使用光学和正电子发射断层扫描报告基因成像 CRISPR 编辑的 CAR-T 细胞疗法

Imaging CRISPR-edited CAR-T cell therapies with optical and positron emission tomography reporters.

CRISPR 工程化微生物组：活体疗法彻底改变血液肿瘤免疫治疗

CRISPR-engineered microbiome: living therapeutics revolutionize blood cancer immunotherapy.

下一代 CAR-NK 细胞治疗：工程化策略、转化挑战与肿瘤免疫治疗的未来展望

Next-generation CAR-NK cell therapy: engineering strategies, translational challenges, and future perspectives in cancer immunotherapy.

实体瘤过继细胞治疗：当前临床格局、挑战与未来方向

Adoptive cell therapies in solid tumors: current clinical landscape, challenges, and future directions.

通过单重和双重沉默 PCSK7/PCSK9 阻断结肠癌转移：增强小鼠与人 T 细胞细胞毒性

Blockade of colon cancer metastasis via single and double silencing of PCSK7/PCSK9: enhanced T cells cytotoxicity in mouse and human.

我们的数据提供了一种 PCSK7 i 策略，可降低细胞表面 ICPs 的水平，从而使 PCSK7 i 在 T 细胞免疫治疗中单独使用或与 PCSK9 抑制剂/沉默剂联合使用合理化。